COG 133
98%
- Product Code: 108188
CAS:
514200-66-9
| Molecular Weight: | 2169.73 g./mol | Molecular Formula: | C₉₇H₁₈₁N₃₇O₁₉ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
COG 133 is primarily researched for its potential therapeutic applications in the field of neurodegenerative diseases, particularly Alzheimer's disease. It is a peptide that interacts with amyloid-beta, a protein fragment implicated in the formation of plaques in the brains of Alzheimer's patients. By binding to amyloid-beta, COG 133 may help prevent the aggregation of these plaques, which are thought to contribute to neuronal damage and cognitive decline. This mechanism makes it a promising candidate for developing treatments aimed at slowing or halting the progression of Alzheimer's disease. Additionally, its neuroprotective properties are being explored for potential use in other conditions involving amyloid-related pathology. Research is ongoing to further understand its efficacy and safety in clinical settings.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿31,806.00 |
+
-
|
COG 133
COG 133 is primarily researched for its potential therapeutic applications in the field of neurodegenerative diseases, particularly Alzheimer's disease. It is a peptide that interacts with amyloid-beta, a protein fragment implicated in the formation of plaques in the brains of Alzheimer's patients. By binding to amyloid-beta, COG 133 may help prevent the aggregation of these plaques, which are thought to contribute to neuronal damage and cognitive decline. This mechanism makes it a promising candidate for developing treatments aimed at slowing or halting the progression of Alzheimer's disease. Additionally, its neuroprotective properties are being explored for potential use in other conditions involving amyloid-related pathology. Research is ongoing to further understand its efficacy and safety in clinical settings.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :